TScan Therapeutics, Inc. 8-K

What Happened
TScan Therapeutics, Inc. (TCRX) announced on January 12, 2026 that it made a corporate presentation available for use in meetings during the 44th Annual J.P. Morgan Healthcare Conference (week of Jan 12, 2026). The presentation was furnished with the Form 8-K as Exhibit 99.1 and will be posted on the company’s investor relations website. The filing notes this disclosure is made under Regulation FD.

Key Details

• Filing date: January 12, 2026 (Current Report on Form 8-K).
• Event: 44th Annual J.P. Morgan Healthcare Conference (week of Jan 12, 2026).
• Document: Corporate Presentation furnished as Exhibit 99.1 to the 8-K.
• Availability: Presentation will also be available on TScan’s investor relations site (https://ir.tscan.com); website content is not incorporated by reference into the 8-K.

Why It Matters
This Form 8-K notifies investors that TScan is sharing a standardized corporate presentation with analysts and investors at a major healthcare investor conference. Under Regulation FD, providing the presentation via an 8-K helps ensure broad, fair access to the information. Investors should review the furnished presentation for any program, pipeline, or strategic updates that could inform investment decisions.